Drugs News and Research

RSS

Intellimedix brings new approach to solve Ebola outbreak

Amidst the Ebola outbreak and subsequent research efforts, Atlanta-based Intellimedix is bringing a new approach to the table. Classical methods of drug development involve performing many experiments only to identify new molecules with a few desired effects.

16 Oct 2014

New oral biologic medication successfully treats precancerous intestinal inflammation

An oral biologic medication has successfully treated chronic, precancerous inflammation in the intestine, according to results of an animal study authored by an MD/PhD student in the University at Buffalo School of Medicine and Biomedical Sciences.

16 Oct 2014

New combination therapy shows promise in treating prostate cancer

Like discriminating thieves, prostate cancer tumors scavenge and hoard copper that is an essential element in the body. But such avarice may be a fatal weakness.

16 Oct 2014

SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years.

16 Oct 2014

Study: Tbx5 protein contributes to formation of epicardium, pericardium, coronary vessels

Congenital heart defects are the most common birth defect, affecting 8 out of every 1,000 newborns according to the National Heart, Lung and Blood Institute. In the U.S., more than 35,000 babies are born annually with some sort of heart defect.

16 Oct 2014

Study: More interventions needed for people with severe mental illnesses in criminal justice system

Responding to the large number of people with serious mental illnesses in the criminal justice system will require more than mental health services, according to a new report.

16 Oct 2014

Hypertensive patients who have psoriasis may need stricter blood pressure control

People with hypertension who also have psoriasis may benefit from tighter blood pressure control, say researchers, particularly if their psoriasis is moderate or severe.

16 Oct 2014

Statement on Ebola epidemic

The Ebola virus is spreading rapidly and to an unexpected extent. The outbreak does not follow the patterns experienced in the past and the virus shows a new disease dynamic in regions, where it has never been recorded before. For this reason, the German National Academy of Sciences Leopoldina, acatech – the German Academy of Science and Engineering, and the Union of the German Academies of Sciences and Humanities have presented a statement on the Ebola epidemic today.

16 Oct 2014

UCSF study: Smoking takes $18.1 billion toll in California

Smoking took an $18.1 billion toll in California – $487 for each resident – and was responsible for more than one in seven deaths in the state, more than from AIDS, influenza, diabetes or many other causes, according to the first comprehensive analysis in more than a decade on the financial and health impacts of tobacco.

16 Oct 2014

Federal prescription-subsidy program improves drug adherence in breast cancer patients

A federal prescription-subsidy program for low-income women on Medicare significantly improved their adherence to hormone therapy to prevent the recurrence of breast cancer after surgery.

16 Oct 2014

State highlights: Ariz. agrees to settlement on health care for prisoners

Prop. 46 would make it mandatory for doctors to consult the database. California would become one of nine states requiring doctors to check before prescribing painkillers to first-time patients. After passing similar laws, Tennessee and New York saw a significant reduction in the number of narcotics prescriptions written. Studies have verified the correlation, but acknowledge that drug abusers may be turning to street drugs, like heroin. Many doctors in California like the database. Some have called it 'indispensable.' But they don't like being told how to practice medicine (Dembosky, 10/14).

16 Oct 2014

Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Researchers from the University of Sheffield have found vital new evidence on how to target and reverse the effects caused by one of the most common genetic causes of Parkinson's.

16 Oct 2014

Pharmaceutical firms share data to enhance transparency of clinical trials for new drugs

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies.

16 Oct 2014

Researchers define the process of Parkinson's disease using genetic mouse model

Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells.

16 Oct 2014

Experts to establish global anti-microbial agenda at 2014 BioInfect Conference

Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, is delighted to be hosting the 2014 BioInfect Conference. A major one day conference looking at the critical issues relating to the development of new anti-infectives and the endemic problem of resistance, will take place at the Alderley Park Conference Centre, Cheshire on the 4th November 2014.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

Cardiometabolic health intervention urged for schizophrenia patients

Research shows high cardiometabolic risk, particularly increased dyslipidaemia and smoking, but little related medical treatment in patients with first-episode schizophrenia.

15 Oct 2014

Penn Medicine announces recipients of new Basser External Research Grant Program

The University of Pennsylvania's Basser Research Center for BRCA has announced $6.9 million to research teams both at Penn and at five other institutions across the United States, aimed at advancing the care of patients living with BRCA1 and BRCA2 mutations through multi-disciplinary collaboration.

15 Oct 2014

State highlights: Supreme Court to hear N.C. scope-of-practice case; states weigh costs of new hepatitis C drugs

The Supreme Court on Tuesday will consider who can whiten teeth in North Carolina, a seemingly small decision that could have major implications for scope-of-practice throughout the country. In North Carolina Board of Dental Examiners v. Federal Trade Commission, the justices will weigh whether the state dental board's decisions - in this case, a decision to not allow anyone but a dentist to whiten teeth - are immune from antitrust protections typically granted to state agencies (Haberkorn, 10/13).

15 Oct 2014

Scientists create light-activated drug to help control type 2 diabetes

Scientists have created a drug for type 2 diabetes that is switched on by blue light, which they hope will improve treatment of the disease.

15 Oct 2014

Drugs News and Research

Intellimedix brings new approach to solve Ebola outbreak

New oral biologic medication successfully treats precancerous intestinal inflammation

New combination therapy shows promise in treating prostate cancer

SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

Study: Tbx5 protein contributes to formation of epicardium, pericardium, coronary vessels

Study: More interventions needed for people with severe mental illnesses in criminal justice system

Hypertensive patients who have psoriasis may need stricter blood pressure control

Statement on Ebola epidemic

UCSF study: Smoking takes $18.1 billion toll in California

Federal prescription-subsidy program improves drug adherence in breast cancer patients

State highlights: Ariz. agrees to settlement on health care for prisoners

Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Pharmaceutical firms share data to enhance transparency of clinical trials for new drugs

Researchers define the process of Parkinson's disease using genetic mouse model

Experts to establish global anti-microbial agenda at 2014 BioInfect Conference

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Cardiometabolic health intervention urged for schizophrenia patients

Penn Medicine announces recipients of new Basser External Research Grant Program

State highlights: Supreme Court to hear N.C. scope-of-practice case; states weigh costs of new hepatitis C drugs

Scientists create light-activated drug to help control type 2 diabetes

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News